Nicole Brogden has been awarded a multi-site U01 grant, funded through the FDA/NIPTE.

The grant will fund a clinical study that will be carried out as a coordinated effort between the Universities of Iowa, Minnesota, and Maryland, titled “Assessing the strength of transdermal systems via two methods: a pharmacokinetic determination vs. a residual drug determination.”